Global Occlusive Coronary Artery Disease Therapeutics Clinical Industry Insights 2014

Page 1

Occlusive Coronary Artery Disease Global Clinical Trials Review, H2, 2014: Order report by calling marketoptimizer.org at +1 888 391 5441 OR send an email on sales@marketoptimizer.org with Occlusive Coronary Artery Disease Global Clinical Trials Review, H2, 2014 in subject line and your contact details. “Occlusive Coronary Artery Disease Global Clinical Trials Review, H2, 2014″ provides data on the Occlusive Coronary Artery Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Occlusive Coronary Artery Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Occlusive Coronary Artery Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope 

 

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type Listings of discontinued trials (suspended, withdrawn and terminated)

Complete report available at http://www.marketoptimizer.org/occlusive-coronary-artery-diseaseglobal-clinical-trials-review-h2-2014.html . Reasons to buy  Understand the dynamics of a particular indication in a condensed manner  Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more  Obtain discontinued trial listing for trials across the globe  Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Inquire for discount @ http://www.marketoptimizer.org/contacts/discount?rname=10711 ( Report price: Single user license- US$ 2500 ) Table of Contents Table of Contents 2


List of Tables3 List of Figures 4 Introduction 5 Occlusive Coronary Artery Disease 5 Report Guidance 5 Clinical Trials by Region 6 Clinical Trials and Average Enrollment by Country 7 Top Countries Contributing to Clinical Trials in Asia-Pacific 9 Top Five Countries Contributing to Clinical Trials in Europe 10 Top Countries Contributing to Clinical Trials in North America 11 Clinical Trials by G7 Countries: Proportion of Occlusive Coronary Artery Disease to Cardiovascular Clinical Trials 12

Buy a Copy of Report @ http://www.marketoptimizer.org/contacts/purchase?rname=10711 . Contact sales@marketoptimizer.org / Call +1 888 391 5441 for further information on “Occlusive Coronary Artery Disease Global Clinical Trials Review, H2, 2014� report OR for any other market research and intelligence needs you may have for your business.


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.